Wen‐Pin Su

1.3k total citations
39 papers, 986 citations indexed

About

Wen‐Pin Su is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wen‐Pin Su has authored 39 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wen‐Pin Su's work include Nanoplatforms for cancer theranostics (10 papers), Lung Cancer Treatments and Mutations (6 papers) and DNA Repair Mechanisms (5 papers). Wen‐Pin Su is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Lung Cancer Treatments and Mutations (6 papers) and DNA Repair Mechanisms (5 papers). Wen‐Pin Su collaborates with scholars based in Taiwan, United States and South Korea. Wen‐Pin Su's co-authors include Wu‐Chou Su, Tilahun Ayane Debele, Chien‐Chung Lin, Wu‐Wei Lai, Cheng Cheng, Jing-Jou Yan, Chong‐Jen Yu, Jin‐Yuan Shih, James Chih‐Hsin Yang and Chien‐Hung Gow and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Wen‐Pin Su

38 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Pin Su Taiwan 16 411 362 311 212 190 39 986
Shanzhou Duan China 19 529 1.3× 261 0.7× 255 0.8× 302 1.4× 186 1.0× 40 1.2k
Kewen Hu China 11 609 1.5× 176 0.5× 223 0.7× 211 1.0× 241 1.3× 12 913
Wenzhi Tu China 18 390 0.9× 143 0.4× 206 0.7× 331 1.6× 166 0.9× 41 900
Chong Ma China 20 466 1.1× 197 0.5× 160 0.5× 321 1.5× 235 1.2× 54 1.2k
Jacqueline Banyard United States 14 593 1.4× 309 0.9× 124 0.4× 169 0.8× 266 1.4× 18 1.1k
En‐Chi Hsu United States 20 705 1.7× 259 0.7× 310 1.0× 169 0.8× 364 1.9× 29 1.3k
Yun Zhu China 23 522 1.3× 253 0.7× 221 0.7× 409 1.9× 244 1.3× 63 1.3k
Boran Cheng China 15 269 0.7× 378 1.0× 121 0.4× 350 1.7× 205 1.1× 29 858
Patricia Juárez Mexico 13 298 0.7× 251 0.7× 140 0.5× 111 0.5× 99 0.5× 26 718
Yongyang Yu China 19 304 0.7× 410 1.1× 173 0.6× 243 1.1× 248 1.3× 63 1.1k

Countries citing papers authored by Wen‐Pin Su

Since Specialization
Citations

This map shows the geographic impact of Wen‐Pin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Pin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Pin Su more than expected).

Fields of papers citing papers by Wen‐Pin Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Pin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Pin Su. The network helps show where Wen‐Pin Su may publish in the future.

Co-authorship network of co-authors of Wen‐Pin Su

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Pin Su. A scholar is included among the top collaborators of Wen‐Pin Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Pin Su. Wen‐Pin Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ying‐Chi, Po‐Ya Chang, Divinah Manoharan, et al.. (2025). Redox disruption using electroactive liposome coated gold nanoparticles for cancer therapy. Nature Communications. 16(1). 3253–3253. 8 indexed citations
2.
Kikuchi, Eiji, Michiel S. van der Heijden, Begoña P. Valderrama, et al.. (2024). 269O Enfortumab vedotin plus pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): Pan-Asian subgroup analysis from EV-302/KEYNOTE-A39. Annals of Oncology. 35. S1507–S1508. 1 indexed citations
3.
Chang, Po‐Ya, Chih‐Wen Pao, Keng‐Shiang Huang, et al.. (2024). Synergistic ROS Generation via Core–Shell Nanostructures with Increased Lattice Microstrain Combined with Single-Atom Catalysis for Enhanced Tumor Suppression. ACS Applied Materials & Interfaces. 16(34). 45356–45370. 3 indexed citations
4.
Hsu, Fei‐Ting, Yu‐Cheng Chin, Li‐Xing Yang, et al.. (2024). Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic Cancer. ACS Nano. 18(42). 28764–28781. 15 indexed citations
5.
Wu, Chao‐Liang, et al.. (2024). APLF facilitates interstrand DNA crosslink repair and replication fork protection to confer cisplatin resistance. Nucleic Acids Research. 52(10). 5676–5697. 6 indexed citations
6.
Chiou, Pei‐Yu, Yi‐Hsuan Wu, Ying‐Chi Chen, et al.. (2023). Prussian blue analog with separated active sites to catalyze water driven enhanced catalytic treatments. Nature Communications. 14(1). 4709–4709. 42 indexed citations
7.
8.
Su, Wen‐Pin, Li‐Xing Yang, Zi‐Chun Chia, et al.. (2022). Polyaniline-Based Glyco-Condensation on Au Nanoparticles Enhances Immunotherapy in Lung Cancer. ACS Applied Materials & Interfaces. 14(21). 24144–24159. 26 indexed citations
9.
Chen, Wenqi, Yi‐Hsin Chien, Po‐Ya Chang, et al.. (2022). Atomically dispersed golds on degradable zero-valent copper nanocubes augment oxygen driven Fenton-like reaction for effective orthotopic tumor therapy. Nature Communications. 13(1). 7772–7772. 27 indexed citations
10.
Su, Guan-Lin, Po‐Ya Chang, Suresh Thangudu, et al.. (2022). Chemical Structure and Shape Enhance MR Imaging-Guided X-ray Therapy Following Marginative Delivery. ACS Applied Materials & Interfaces. 14(11). 13056–13069. 12 indexed citations
11.
12.
Debele, Tilahun Ayane, Ping-Ching Wu, Yu‐Feng Wei, et al.. (2021). Transferrin Modified GSH Sensitive Hyaluronic Acid Derivative Micelle to Deliver HSP90 Inhibitors to Enhance the Therapeutic Efficacy of Brain Cancers. Cancers. 13(10). 2375–2375. 8 indexed citations
13.
Hu, Lina, et al.. (2021). Prognostic role of MUC-2 expression in patients with gastric carcinoma: a systematic review and meta-analysis. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Tsai, Yuh‐Shyan, et al.. (2021). Study on the pathophysiological mechanism responsible for lower urinary tract symptoms associated with prostate cancer using an animal model. LUTS Lower Urinary Tract Symptoms. 13(3). 390–399. 1 indexed citations
15.
16.
Chang, Song‐Bin, Yen‐Ju Chen, Chien‐Chen Lai, et al.. (2020). The HLTF–PARP1 interaction in the progression and stability of damaged replication forks caused by methyl methanesulfonate. Oncogenesis. 9(12). 104–104. 12 indexed citations
17.
Debele, Tilahun Ayane, et al.. (2020). Combination Delivery of Alpha-Tocopheryl Succinate and Curcumin Using a GSH-Sensitive Micelle (PAH-SS-PLGA) to Treat Pancreatic Cancer. Pharmaceutics. 12(8). 778–778. 15 indexed citations
18.
19.
Su, Wen‐Pin, Song‐Bin Chang, Wen‐Tai Chiu, et al.. (2017). Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways. Scientific Reports. 7(1). 3879–3879. 13 indexed citations
20.
Lin, Chien‐Chung, Vincent S. Tseng, Jing Yan, et al.. (2010). Malignant pleural effusion cells show aberrant glucose metabolism gene expression. European Respiratory Journal. 37(6). 1453–1465. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shanzhou Duan Breakdown of academic impact, for papers by Kewen Hu Breakdown of academic impact, for papers by Wenzhi Tu Breakdown of academic impact, for papers by Chong Ma Breakdown of academic impact, for papers by Jacqueline Banyard Breakdown of academic impact, for papers by En‐Chi Hsu Breakdown of academic impact, for papers by Yun Zhu Breakdown of academic impact, for papers by Boran Cheng Breakdown of academic impact, for papers by Patricia Juárez Breakdown of academic impact, for papers by Yongyang Yu
Rankless by CCL
2026